Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

CYTRX BLOOD AGENT ENTERS PHASE II

Feb. 21, 1992

PARKINSON'S TREATMENT DISAPPOINTING

Feb. 20, 1992

IVAX UNIT BEGINS ALZHEIMER'S TRIALS

Feb. 20, 1992

SYNTRO-HOECHST ANIMAL VACCINE DEAL

Feb. 20, 1992

INNOVET TO ACQUIRE COLLABORATOR

Feb. 20, 1992

ENDOTHELIN STRUCTURE DESCRIBED

Feb. 20, 1992

TAXOL MAKER CLOSES PRIVATE PLACEMENT

Feb. 20, 1992

SANDOZ COMPLETES SYSTEMIX TENDER OFFER

Feb. 20, 1992

EPITOPE TOLD TO EXPAND DISEASE TARGETS

Feb. 20, 1992

WALL ST. VENTS FRUSTRATION AT CENTOCOR

Feb. 20, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...